{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:55:05Z","timestamp":1789073705075,"version":"build-2803163510"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,1]]},"DOI":"10.1093\/hmg\/ddn419","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T20:45:39Z","timestamp":1228855539000},"page":"898-910","source":"Crossref","is-referenced-by-count":98,"title":["17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse"],"prefix":"10.1093","volume":"18","author":[{"given":"Keisuke","family":"Tokui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Waza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Minamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,12,9]]},"reference":[{"key":"key\n\t\t\t\t20170522132258_DDN419C1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nrg1690","article-title":"Therapeutics development for triplet repeat expansion diseases","volume":"6","author":"Di Prospero","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2990.2007.00830.x","article-title":"Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy","volume":"33","author":"Adachi","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/hmg\/5.9.1253","article-title":"Founder effect in spinal and bulbar muscular atrophy (SBMA)","volume":"5","author":"Tanaka","year":"1996","journal-title":"Hum. Mol. Genet."},{"issue":"Pt 1","key":"key\n\t\t\t\t20170522132258_DDN419C4","first-page":"209","article-title":"X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain","volume":"112","author":"Sobue","year":"1989"},{"key":"key\n\t\t\t\t20170522132258_DDN419C5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/brain\/awh381","article-title":"Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients","volume":"128","author":"Adachi","year":"2005","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170522132258_DDN419C6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153537020322800201","article-title":"Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery","volume":"228","author":"Pratt","year":"2003","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"key\n\t\t\t\t20170522132258_DDN419C7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yfrne.2004.03.001","article-title":"The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons","volume":"25","author":"Poletti","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C8","first-page":"962","article-title":"Heat shock protein 90 inhibition by 17-allylamino-17- demethoxygeldanamycin: a novel therapeutic approach for treating hormone-refractory prostate cancer","volume":"8","author":"Neckers","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170522132258_DDN419C9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrn1587","article-title":"Modulation of neurodegeneration by molecular chaperones","volume":"6","author":"Muchowski","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1391.012","article-title":"Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress","volume":"1113","author":"Workman","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1298","article-title":"17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration","volume":"11","author":"Waza","year":"2005","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522132258_DDN419C12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s00280-004-0947-2","article-title":"Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models","volume":"56","author":"Smith","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000101849","article-title":"Small molecule inducers of heat-shock response reduce polyQ-mediated huntingtin aggregation. A possible therapeutic strategy","volume":"4","author":"Herbst","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"key\n\t\t\t\t20170522132258_DDN419C14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00280-001-0380-8","article-title":"Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats","volume":"49","author":"Egorin","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nm1005-1052","article-title":"Targeting toxic proteins for turnover","volume":"11","author":"La Spada","year":"2005","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522132258_DDN419C16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/502","article-title":"Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1","volume":"19","author":"Cummings","year":"1998","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0896-6273(03)00606-8","article-title":"The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg","volume":"40","author":"Ciechanover","year":"2003","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522132258_DDN419C18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522132258_DDN419C19","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","article-title":"Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release","volume":"10","author":"Jana","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molcel.2004.12.021","article-title":"Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation","volume":"17","author":"Bennett","year":"2005","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170522132258_DDN419C21","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington\u2019s disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522132258_DDN419C22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neurobiolaging.2006.05.015","article-title":"Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy","volume":"28","author":"Rusmini","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"key\n\t\t\t\t20170522132258_DDN419C23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.200709080","article-title":"Impaired ubiquitin-proteasome system activity in the synapses of Huntington\u2019s disease mice","volume":"180","author":"Wang","year":"2008","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.20207","article-title":"Generalized brain and skin proteasome inhibition in Huntington\u2019s disease","volume":"56","author":"Seo","year":"2004","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/hmg\/ddi064","article-title":"Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation","volume":"14","author":"Bowman","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/hmg\/ddi423","article-title":"Proteasome impairment does not contribute to pathogenesis in R6\/2 Huntington\u2019s disease mice: exclusion of proteasome activator REGgamma as a therapeutic target","volume":"15","author":"Bett","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1083\/jcb.200306038","article-title":"Huntingtin forms toxic NH2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity","volume":"163","author":"Zhou","year":"2003","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C28","doi-asserted-by":"crossref","first-page":"13935","DOI":"10.1074\/jbc.M107706200","article-title":"Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival","volume":"277","author":"Ding","year":"2002","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522132258_DDN419C29","doi-asserted-by":"crossref","first-page":"11653","DOI":"10.1523\/JNEUROSCI.23-37-11653.2003","article-title":"Neuronal induction of the immunoproteasome in Huntington\u2019s disease","volume":"23","author":"Diaz-Hernandez","year":"2003","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170522132258_DDN419C31","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nbt851","article-title":"A transgenic mouse model of the ubiquitin\/proteasome system","volume":"21","author":"Lindsten","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C32","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/75406","article-title":"Short-lived green fluorescent proteins for quantifying ubiquitin\/proteasome-dependent proteolysis in living cells","volume":"18","author":"Dantuma","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C33","first-page":"705","article-title":"Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells","volume":"10","author":"Whitesell","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C34","doi-asserted-by":"crossref","first-page":"22796","DOI":"10.1074\/jbc.271.37.22796","article-title":"Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin","volume":"271","author":"Mimnaugh","year":"1996","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522132258_DDN419C35","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/0008-5472.CAN-03-3531","article-title":"Ubiquitination and proteasomal degradation of nucleophosmin-anaplastic lymphoma kinase induced by 17-allylamino-demethoxygeldanamycin: role of the co-chaperone carboxyl heat shock protein 70-interacting protein","volume":"64","author":"Bonvini","year":"2004","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170522132258_DDN419C36","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1523\/JNEUROSCI.23-06-02203.2003","article-title":"Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein","volume":"23","author":"Adachi","year":"2003","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2007.08.005","article-title":"The ubiquitin-proteasome pathway in health and disease of the nervous system","volume":"30","author":"Hegde","year":"2007","journal-title":"Trends Neurosci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C38","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.97.6.2898","article-title":"Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington\u2019s disease","volume":"97","author":"Wyttenbach","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522132258_DDN419C39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522132258_DDN419C40","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522132258_DDN419C41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522132258_DDN419C42","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.2978-04.2004","article-title":"Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice","volume":"24","author":"Zu","year":"2004","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/77046","article-title":"Gene-expression profile of the ageing brain in mice","volume":"25","author":"Lee","year":"2000","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0306-4522(00)00067-1","article-title":"Decreased levels of proteasome activity and proteasome expression in aging spinal cord","volume":"98","author":"Keller","year":"2000","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20170522132258_DDN419C45","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522132258_DDN419C46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002800000242","article-title":"Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1","volume":"47","author":"Egorin","year":"2001","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C47","first-page":"308","article-title":"Comparison of geldanamycin (NSC-122750) and 17-allylaminogeldanamycin (NSC-330507D) toxicity in rats","volume":"38","author":"Page","year":"1997","journal-title":"Proc. Am. Assoc. Cancer Res."},{"key":"key\n\t\t\t\t20170522132258_DDN419C48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00689048","article-title":"Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent","volume":"36","author":"Supko","year":"1995","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C49","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-06-2468","article-title":"Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity\u2014pharmacodynamic drug-drug interaction modeling","volume":"13","author":"Wetzler","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170522132258_DDN419C50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00280-004-0939-2","article-title":"In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative","volume":"56","author":"Hollingshead","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3816\/CLM.2006.n.034","article-title":"17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I study","volume":"6","author":"Shadad","year":"2006","journal-title":"Clin. Lymphoma Myeloma"},{"key":"key\n\t\t\t\t20170522132258_DDN419C52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/pbc.21508","article-title":"Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17-DMAG, KOS-1022) by the pediatric preclinical testing program","volume":"51","author":"Smith","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"key\n\t\t\t\t20170522132258_DDN419C53","first-page":"2385","article-title":"Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations","volume":"58","author":"Egorin","year":"1998","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170522132258_DDN419C54","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00109-007-0251-9","article-title":"Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response","volume":"85","author":"Zhang","year":"2007","journal-title":"J. Mol. Med."},{"key":"key\n\t\t\t\t20170522132258_DDN419C55","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","article-title":"Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington\u2019s disease","volume":"10","author":"Sittler","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C56","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1073\/pnas.0506249102","article-title":"Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease","volume":"102","author":"Katsuno","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522132258_DDN419C57","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/hmg\/11.5.515","article-title":"Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy","volume":"11","author":"Bailey","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C58","doi-asserted-by":"crossref","first-page":"26714","DOI":"10.1074\/jbc.M601603200","article-title":"CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation","volume":"281","author":"Al-Ramahi","year":"2006","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522132258_DDN419C59","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","article-title":"CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model","volume":"27","author":"Adachi","year":"2007","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20170522132258_DDN419C60","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1172\/JCI29715","article-title":"The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins","volume":"117","author":"Dickey","year":"2007","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170522132258_DDN419C61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1102-1185","article-title":"Pharmacological prevention of Parkinson disease in Drosophila","volume":"8","author":"Auluck","year":"2002","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522132258_DDN419C62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1471-4159.2002.00835.x","article-title":"Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia","volume":"81","author":"Lu","year":"2002","journal-title":"J. Neurochem."},{"key":"key\n\t\t\t\t20170522132258_DDN419C63","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jnr.10139","article-title":"Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis","volume":"67","author":"Murphy","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"key\n\t\t\t\t20170522132258_DDN419C64","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","article-title":"Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"9","author":"Katsuno","year":"2003","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522132258_DDN419C65","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1038\/sj.emboj.7601338","article-title":"A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes","volume":"25","author":"Hamazaki","year":"2006","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170522132258_DDN419C66","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/embo-reports\/kve246","article-title":"CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein","volume":"2","author":"Murata","year":"2001","journal-title":"EMBO Rep."},{"key":"key\n\t\t\t\t20170522132258_DDN419C67","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C68","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/10.10.1039","article-title":"Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death","volume":"10","author":"Adachi","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522132258_DDN419C69","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.molcel.2006.11.015","article-title":"Cooperation of multiple chaperones required for the assembly of mammalian 20S proteasomes","volume":"24","author":"Hirano","year":"2006","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170522132258_DDN419C70","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1128\/MCB.00509-07","article-title":"Rpn10-mediated degradation of ubiquitinated proteins is essential for mouse development","volume":"27","author":"Hamazaki","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522132258_DDN419C71","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0076-6879(05)99034-4","article-title":"Monitoring of ubiquitin-dependent proteolysis with green fluorescent protein substrates","volume":"399","author":"Menendez-Benito","year":"2005","journal-title":"Methods Enzymol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/18\/5\/898\/17248588\/ddn419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T23:41:11Z","timestamp":1557963671000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddn419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,9]]},"references-count":71,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,12,9]]},"published-print":{"date-parts":[[2009,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddn419","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12,9]]}}}